SERUM DEPRIVATION INDUCES EWING SARCOMA CELLS TO ADOPT A MORE INVASIVE PHENOTYPE AND TO UP REGULATE RHO-MKL TRANSCRIPTIONAL SIGNALING Merlin Airik, Melanie.

Slides:



Advertisements
Similar presentations
John A. Barrett Ph.D. Ziopharm Oncology, Boston MA 02129
Advertisements

INTEGRATED ANALYSIS OF THE MOLECULAR DEREGULATIONS OF THE MDM2:P53 AXIS IN DDLPS KATE LYNN BILL, JEANNINE GARNETT, CHAD CREIGHTON, XIAOYAN MA, ISABELLE.
THE EWS-FLI1 ONCOGENE DISRUPTS NORMAL DEVELOPMENTAL REGULATION OF POLYCOMB- MODULATED TRANSCRIPTIONAL PROGRAMS Ashley Harris, Natashay Bailey, Laurie Svoboda.
Alpha5 integrin dependent 3D attachment, appearance, and migration (Not 2D) (cell-derived) (pliable)
Interactions Between Vitamin D and Androgen Receptor Signaling in Prostate Cancer Cells Nancy L. Weigel, Ph.D. Baylor College of Medicine.
Medical Genetics & Genomics Guri Tzivion, PhD Extension 506 BCHM 560: January 2015 Windsor University School of Medicine.
Flow Cytometric Detection of Bone Marrow CD99+CD45- Cells in Ewing Sarcoma Steven DuBois, MD.
Raphael Pollock, MD, PhD Principal Investigator
Introduction to Neoplasia
Modulation of the Cellular Phenotype in Human Colon Adenocarcinoma Cells by Folic Acid and Polyamine Pools Nathan W. Sweeney, Julie A. Buckmeier, Christina.
Circulating Tumor Cells
Cancer Genetics Is Cancer a Genetic Disease? Cancer is not a classic genetic disease, instead, Genetic background (set-up) has a definite role in cancer.
Investigation Of Cell-Adhesion Molecules In Prostate Cancer Progression Abstract. Lakshana Sreenivasan 4,5, Edward Abril 4,5, Kathleen McDaniel 4,5, Raymond.
MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.
Cancer Biology. 2 Outline 1.How do cancer cells differ from normal cells? Tumor progression Molecular basis for cancer.
Metastasis Figure 20-1 Molecular Biology of the Cell (© Garland Science 2008) Metastatic tumors.
Cellular Senescence What is it? What causes it? Why is it important (cancer and aging)?
Tumor Immunology: Definitions: -Tumor (neoplasm): unchecked cellular growth. -Two types: 1-Benign: controlled tumor. 2-Malignant: uncontrolled tumor. -Malignant.
Chapter 19 Cancer and the Immune System Dr. Capers.
HUMAN IMMUNODEFICIENCY VIRUS-1 TAT PROTEIN UPREGULATES IL-6 AND IL-8 EXPRESSION IN HUMAN BREAST CANCER CELLS Yong Woo Lee 1, Natasha Kyprianou 1, Avindra.
Metastatic Breast Cancer: One Size Does Not Fit All Clifford Hudis, M.D. Chief, Breast Cancer Medicine Service MSKCC.
Malignant Melanoma and CDKN2A
MICROARRAY ANALYSIS OF EWS/FLI IN EWING'S SARCOMA REVEALS A CRITICAL ROLE FOR NKX2.2 IN ONCOGENESIS Stephen Lessnick, MD, PhD Division of Pediatric Hematology/Oncology.
3.1.3.A Understanding Cancer What is Cancer.
Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-regulation of Calreticulin Expression Speaker: Yi-Chien.
The c-Met receptor contributes to motility and invasion in high grade STS; a potential therapeutic target Sarah E. Myers, Theresa G. Nguyen, Quan-Sheng.
Chapter 21 Cancer and the Immune System Dr. Capers
SARC Career Development Award Program Richard Gorlick, MD Lee Helman, MD.
Control of Gene Activity Chapter 17. Controlling gene activity Remember to control the cell one must control protein synthesis. Remember to control the.
Calculus and Cancer Drug Development Studies Stephan Gysin, PhD UCSF Helen Diller Family Comprehensive Cancer Center.
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor.
When will the diagnosis of Circulating tumor cells (CTC) help to patients? Martin Pešta, Ondřej Topolčan Department of Internal Medicine II, Faculty of.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
BioH Chapter 14 – Control over Genes. Control of Gene Expression Cells are selective about which genes they require This depends upon:  Cell type  Specific.
IGF-1R: A key linker between chemoresistance and cancer stem cells in epithelial ovarian cancer cells Ram Kumar Singh, Ankit Jinager, Ajit Dhadwe, Abhijit.
Poster Discussion 2 - Biology Genome Transcriptome Proteome Metastasome.
Jessica L. Feig PhD1, Keith M. Giles PhD2, Iman Osman MD2, Andrew G
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
Potential therapeutic target & predictive biomarker Oncogenic IGFBP2 Sonya Song ( 宋韦 ) Beijing Shijitan Hospital Department of Oncology The Capital Medical.
FERM domain proteins and their involvement in metastasis Merlin and ERM proteins: unappreciated roles in cancer development? A McClatchey Nat Rev Cancer.
Benign Versus Malignant Tumors
Neoplasia VI DR OSAMA I NASSIF FRCPC CONSULTANT & ASSOCIATE PROFESSOR DEPARTMENT OF PATHOLOGY, KAUH Neoplasia VI DR OSAMA I NASSIF MD,FRCPC CONSULTANT.
1. Epithelial Mesenchymal Transition ( EMT ) 2 3.
MECHANISM OF ACTION STUDIES IN A549 CELLS SHOW THAT MARCKS-INHIBITORY PEPTIDES (IN THIS CASE MANS PEPTIDE) BLOCKS PHOSPHORYLATION OF MARCKS IN RESPONSE.
Layla Barkal and Jessica Perez
MITOSIS: CELL CYCLE CONTROL. OVERVIEW: Has 4 phases – G 1, S, G 2, and M Driven by specific molecular signals present in the cytoplasm Controlled by a.
Abstract In response to numerous pathologic stimuli, the myocardium undergoes a hypertrophic response characterized by increased.
The Problem of Cancer. What are cancer cells ? Cancerous growth involves unrestrained proliferation (malignancy) and spread (metastasis). Caused by: mutations.
Yuna Jo. Introduction Prostate cancer (PCa) continues to burden the Western world with its high rates of incidence and mortality despite the.
E cadherin and Metastasis
Are macrophages interesting targets for anti-cancer therapy?
Cellular Senescence What is it? What causes it? Why is it important
HMG-COA reductase regulates CCL17-induced colon cancer cell migration via gernaylgeranylation and RhoA activation Amr Al-Haidari Department of Clinical.
Fig. 1 Increased MIR155HG expression correlates with glioma grade and mesenchymal transition and confers a poor prognosis in GBM patients. (A) The level.
Epithelial-to-Mesenchymal Transitions Circulating Tumor Cells
Multidrug resistance drives partial EMT to complete EMT: study the network of EMT mediators 楊毅輝1*、陳奇雍2、孟子青3、王正康4# 1國所防醫學院醫學系,2國防醫學院生命科學研究所,3國防醫學院生物化學研究所,4中央研究院生物化學研究.
Chapter 6: The Composition of Bone
OMICS Journals are welcoming Submissions
Program Goals. Program Goals Immunotherapy of B-cell Malignancies.
Activation of Oncogenic Pathways in Idiopathic Pulmonary Fibrosis
Activating Invasion and Metastasis
Activating Invasion and Metastasis
Chadrick E. Denlinger, MD, John S. Ikonomidis, MD, PhD, Carolyn E
ID Proteins Regulate Diverse Aspects of Cancer Progression and Provide Novel Therapeutic Opportunities  Radhika Nair, Wee Siang Teo, Vivek Mittal, Alexander.
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Endothelial Cells Form a Phalanx to Block Tumor Metastasis
Nat. Rev. Urol. doi: /nrurol
p53 loss affects several steps of the metastatic process.
Presentation transcript:

SERUM DEPRIVATION INDUCES EWING SARCOMA CELLS TO ADOPT A MORE INVASIVE PHENOTYPE AND TO UP REGULATE RHO-MKL TRANSCRIPTIONAL SIGNALING Merlin Airik, Melanie Krook, Christopher Scannell, Andrew Haak, Richard R. Neubig, Elizabeth R. Lawlor Departments of Pediatrics, Pathology and Pharmacology University of Michigan, Ann Arbor, Michigan, USA

Merlin Airik, PhD Post-doctoral fellow Melanie Krook Graduate student Chris Scannell Graduate student Andrew Haak Graduate student Richard R. Neubig, MD, PhD Dept of Pharmacology Sunbeam Foundation, Russell G. Adderley Endowment UM SARC Sarcoma SPORE (NIH), Liddy Shriver Sarcoma Initiative

Ewing Sarcoma: Metastasis Can be an early or late event Many patients with localized disease relapse at metastatic sites months and even years following an initial clinical remission Phenotypic plasticity of cancer cells is well-characterized in epithelial malignancies: cells transition back and forth between metastatic and non-metastatic phenotypes Epithelial to mesenchymal transition (EMT) is implicated in the initiation of metastasis of epithelial malignancies Does phenotypic plasticity exist in Ewing sarcoma? What molecular pathways drive metastasis of Ewing sarcoma cells?

Serum deprivation induces cell cycle arrest & morphologic change in Ewing sarcoma cells 10%FBS 0%FBS A673 CHLA9 10%0% 10%0% A. C. B. D. A673 CHLA9 + 10% x 2.5hr

A.B. Serum deprived cells exhibit enhanced motility and migration 10% 0% 10%0% C.D. xCelligence CIM-plate migration assay24hr end-point migration assay

Rho-Transcriptional Signaling Rho-GTPases contribute to cell movement and cancer metastasis – Change so actin cytoskeleton directly in cytoplasm – Activation of downstream transcriptional signaling via translocation of MKL/MRTF to nucleus Rho-MKL transcriptional axis is required for breast cancer and melanoma metastasis (Medjkane, Nature Cell Biol 2009) – MYL9 and MYH9 implicated as metastasis effectors Nature Reviews Molecular Cell Biology 11, (May 2010) MKL

Serum starved Ewing sarcoma cells show dramatic changes in arrangement of the actin cytoskeleton A. B. 10% FBS0% FBS DAPI Phalloidin

Nuclear localization of MKL & upregulation of MYL9 in serum starved Ewing sarcoma cells MYL9 10%0%+10% x24h Normalized ratio MYL9MYH9 10% 0% Normalized ratio A. C. B.

Inhibition of the Rho-MKL transcriptional axis restores morphology & actin cytoskeleton MKL CCG-1423 CCG-1423: a small molecule inhibitor of RhoA transcriptional signaling Evelyn,…Neubig. Molecular Cancer Therapy 2007 A.B. 10% FBS 0% FBS + 800nM CCG-1423 DAPI Phalloidin

0h 24h 12h A673 SFM A673 SFM + 800nM CCG-1423 Pharmacologic inhibition of the Rho-MKL transcriptional axis blocks Ewing sarcoma cell motility

Summary Phenotypic plasticity exists in Ewing sarcoma cells in vitro Serum starvation induces a rapid and reversible switch to a more migratory phenotype The migratory phenotype is associated with increased nuclear localization of transcriptional co-activator MKL and increased expression of the metastasis-associated MKL target gene MYL9 Small molecule inhibitors of Rho-MKL transcriptional axis block Ewing cell migration Metastatic Relapse Activation of Rho-MKL signaling Opportunity for metastasis prevention? Growth factor deprivation Diminished blood supply? Rapid tumor growth? Altered microenvironment? Post-chemotherapy?